Skip to main content
Onesource Specialty Pharma Limited logo

Onesource Specialty Pharma Limited — Investor Relations & Filings

Ticker · ONESOURCE ISIN · INE013P01021 LEI · 335800TP5C932B9IQT98 BSE.NS Manufacturing
Open in API
Filings indexed 156 across all filing types
Latest filing 2026-05-19 Call Transcript
Country IN India
Listing BSE.NS ONESOURCE

About Onesource Specialty Pharma Limited

https://www.onesourcecdmo.com/

Onesource Specialty Pharma Limited is a specialized Contract Development and Manufacturing Organization (CDMO) providing integrated solutions for complex pharmaceutical products. The company focuses on the development and large-scale manufacturing of specialty injectables, softgel capsules, and complex formulations. Its service portfolio encompasses the entire product lifecycle, including formulation development, clinical trial supply, and commercial-stage production. Onesource operates advanced manufacturing facilities designed to meet global regulatory standards, catering to diverse therapeutic areas. By leveraging technical expertise in sterile products and differentiated dosage forms, the organization supports global pharmaceutical partners in bringing high-entry-barrier medicines to market. The platform is built on a foundation of quality compliance and operational excellence to ensure the delivery of critical healthcare solutions.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 98% confidence The document is labeled as the “Transcript of Earnings Call pertaining to Audited Financial Results of the Company for the quarter and financial year ended March 31, 2026,” with a full management presentation and Q&A format. This matches the definition of a conference call transcript (earnings call). Therefore, it should be classified as a Call Transcript.
2026-05-19 English
Intimation of Transcript of Earnings call dated May 13, 2026
Call Transcript Classification · 95% confidence The document consists of a letter to stock exchanges and the full transcript of the company’s Q4 FY ’26 earnings conference call, including opening remarks by management and CFO commentary, fitting the definition of a Call Transcript. There is no indication of it being a brief announcement or presentation; it is the complete transcript of the earnings call. Therefore, it is classified as CT.
2026-05-19 English
Updates
Audit Report / Information Classification · 95% confidence The document is an Independent Auditor’s Report issued by Deloitte Haskins & Sells on the Standalone Financial Results for the year ended March 31, 2026 and the limited review of the quarterly results for the quarter ended March 31, 2026. It is a standalone audit report on financial results (per SEBI LODR Regulation 33) and not the full annual report of the company. Therefore, it fits the definition of a standalone audit report. FY 2026
2026-05-19 English
Updates
Board/Management Information Classification · 100% confidence The document is a formal communication addressed to stock exchanges regarding the resignation of a senior management personnel, specifically the Senior Vice President & Head of Technical Development. It references Regulation 30 of SEBI Listing Regulations, which pertains to disclosure obligations for material events including changes in senior management. The content includes an acknowledgment of the resignation letter and a relieving letter for the employee. There is no financial data, report, or presentation included. The document is clearly an announcement of a management change rather than a financial report or other filing type. Therefore, the appropriate classification is 'Board/Management Information' (MANG). The document length is short and focused solely on management change, supporting this classification with high confidence.
2026-05-19 English
In furtherance to the intimation dated May 13, 2026, w.r.t the resignation of SMP, please find enclosed the resignation document.
Board/Management Information Classification · 92% confidence The document is an official intimation to stock exchanges under SEBI Listing Regulations about the resignation of a Senior Vice President (Senior Management Personnel). This clearly falls under announcements of changes in senior management. It is not a formal financial report, but a management change announcement.
2026-05-19 English
Updates
Regulatory Filings Classification · 80% confidence The document is a short exchange filing notifying BSE and NSE of a government approval for an expansion project (Karnataka Industrial Policy incentives). It is a general regulatory announcement rather than a detailed financial report, earnings release, dividend notice, or management change. Hence, it falls under Regulatory Filings (RNS).
2026-05-16 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.